Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VIBRA: Vaginal Prasterone for Vaginal Atrophy in Breast Cancer
NCT04705883Phase 4Completed
- Sponsor
- Hospital Clínic de Barcelona
- Start
- Sep 2020
- Primary completion
- Nov 2021
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 4 trial of dehydroepiandrosterone in vulvar atrophy, sponsored by Hospital Clínic de Barcelona. Started Sep 2020; status: completed.
02
Drugs
dehydroepiandrosterone
03
Conditions
vulvar atrophy
Beyond the preview
Go deeper on NCT04705883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04705883.